Sign up for a free recipe e-book →

Clarissa's Blog

Ice-cream

Published by

Clarissa

on

I now like ice-cream. Maybe these are age-related changes because I didn’t even like it as a kid. Also, it might be the fault of the new ice-cream parlor we have in town because it’s only their ice-cream that I crave. I’ve already had it 3 times just this month when normally I’d have it one every two years.

Or maybe I have COVID. Somebody I know suggested this as a possibility and said I should get tested. For some people, COVID is now the global theory of everything.

It’s really good ice-cream at that parlor. They have adult, not too sweet flavors and very high-quality Italian cherries to put on top. Expensive as the dickens, of course.

2 responses to “Ice-cream”

  1. Tal Hartsfeld Avatar
    Tal Hartsfeld

    “For some people COVID is now the global theory of everything”.
    Well, “Seek and ye shall find”. Seeking scapegoats is always easier than trying to find the real cause of dilemmas, hardships, and aggravations. Similar to how those who seek sex-change operations scapegoat their gender as somehow being the cause of all their personal issues.

    Like

    Reply
  2. methylethyl Avatar
    methylethyl

    Off-Topic, but thought you might be interested in the book Toby is talking about in this article, as it addresses the genesis of the opioid epidemic in the US, which you have talked about previously:

    https://tobyrogers.substack.com/p/is-mckinsey-and-company-the-deep

    Relevant excerpt:
    “McKinsey worked with Purdue Pharma to “turbocharge” sales of OcyContin (extended release heroin). As part of that contract, McKinsey proposed that Purdue rebate $14,810 to CVS (another McKinsey client) for every overdose attributable to the pills they sold thus compensating CVS for every lost customer. McKinsey also advised J&J that supplied the raw ingredients for OxyContin from genetically engineered Tasmanian poppies that are “particularly rich in opioids.” In an extreme conflict of interest, the FDA’s Center for Drug Evaluation and Research, that regulates prescription opioids, was also a McKinsey client.”

    Liked by 1 person

    Reply

Leave a comment

A conservative literary critic and college professor

Recent posts